Berry lozenges tested as cancer shield in healthy volunteers
NCT ID NCT01961869
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tested whether black raspberry confections (like lozenges) could help prevent oral cancer. Sixty-seven healthy volunteers ate different versions of the confection to see which was most acceptable and how it affected genes and chemicals linked to cancer. The goal was to find the best way to deliver black raspberry's cancer-fighting compounds.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
black raspberry confection (lyophilized black raspberry powder)
What this could lead to
If successful, this could point toward a simple dietary approach to help prevent oral cancer in healthy people.
What could go wrong
This is a very early Phase 1 study in healthy volunteers, not patients. It focuses on taste, safety, and biological markers, not on actually preventing cancer. The results may not lead to any proven prevention method.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Columbus, Ohio, 43210, United States